Sionna Therapeutics (NASDAQ:SION), a clinical-stage biopharma focused on developing cystic fibrosis therapies, opened well above its initial public offering price on Friday in its first trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback